PT-141 (Intimacy & Desire Peptide)

A peptide-based compound developed to influence brain pathways involved in sexual desire and arousal.

PT-141, also known as bremelanotide, is different from many sexual-wellness compounds because its primary action is within the central nervous system rather than directly increasing genital blood flow.

Why PT-141?

❤️ Desire & Arousal
PT-141 activates melanocortin receptors involved in neural pathways associated with sexual motivation and arousal.

🧠 Brain-Based Mechanism
Rather than working primarily on blood vessels, PT-141 acts through melanocortin signaling in the brain.

✨ Sexual Wellness
Bremelanotide has been clinically investigated for sexual-desire disorders and has demonstrated biological activity in humans.

⚡ Different from PDE5 Inhibitors
PT-141 has a fundamentally different mechanism from medications such as sildenafil, which primarily enhance blood flow.

What Makes PT-141 Different?

PT-141 is essentially a brain-first approach to sexual arousal.

Its activity at melanocortin receptors—particularly MC4R—distinguishes it from conventional erectile-dysfunction medications and makes it relevant to research involving desire, arousal, and sexual behavior.

Product Details

Product: PT-141 (Bremelanotide)
Category: Intimacy & Desire Peptide
Form: Lyophilized powder
Storage: Keep refrigerated at 2–8°C
Packaging: Individually sealed vial

Bremelanotide is an active pharmaceutical ingredient with an FDA-approved prescription product for a specific indication and population. This listing should not be interpreted as establishing that this particular product is FDA-approved or appropriate for any medical use.